Detalhe da pesquisa
1.
Dupilumab Improves Clinical Scores in Children and Adolescents With Moderate to Severe Atopic Dermatitis: A Real-World, Single-Center Study.
J Allergy Clin Immunol Pract
; 10(9): 2378-2385, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35753667